Ending unnecessary cancer screenings can take over a decade

	Prostate Cancer
	The latest prostate cancer news from News Medical

	Ending unnecessary cancer screenings can take over a decade Stopping the widespread use of unnecessary, potentially even harmful, cancer screenings can take up to 13 years and potentially even longer after new guidelines are put in place, according to a new study.

	Glucocorticoid receptor plays dual role in prostate cancer progression A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the circumstances.

			Inflammation drives early prostate cancer through cellular reprogramming Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer formation are poorly understood.

			Study reveals how FOXA1 mutations drive prostate cancer and therapy resistance A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene-commonly altered in prostate cancer-drive tumor initiation formation and therapeutic resistance.

	In a first, Trump and GOP-led Congress prepare to swell ranks of U.S. uninsured Last September, Alton Fry went to the doctor concerned he had high blood pressure. The trip would result in a prostate cancer diagnosis.

	Researchers identify gene driving aggressive prostate cancer Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form.

	TTUHSC researchers seek to understand TBX2's role in bone metastasis of prostate cancer The American Cancer Society estimates that more than 313,780 cases of prostate cancer will be diagnosed in the United States in 2025, resulting in approximately 35,770 deaths.

	Uncovering hidden disease clues with nanoparticles and AI Imagine Spartan Stadium packed with 75,000 fans, all wearing green and white jerseys - except one person in a solid green shirt.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025